Research progress in risk factors and evaluation tools for nausea and vomiting after hepatic artery chemoembolization in liver cancer patients

VernacularTitle:肝癌患者肝动脉化疗栓塞术后恶心和呕吐的危险因素及评估工具研究进展
Author: Yi LIANG ¹ ; Zhongting YAN ; Yuhuan SANG ; Bo YANG ; Fang WANG ; Yuan YUAN ; Mei JU
Author Information

1. 646000 四川泸州西南医科大学护理学院
Keywords: liver cancer; transcatheter arterial chemoembolization; nausea; vomiting; risk factor
From: Journal of Interventional Radiology 2024;33(5):565-570
CountryChina
Language:Chinese
Abstract: Primary liver cancer(PLC)is a common malignant tumor in China.It ranks second in the cause of tumor mortality and it is a serious threat to the lives and health of people.Transcatheter arterial chemoembolization(TACE)is the preferred treatment for patients with HCC who cannot be surgically cured,which is of great significance for prolonging the patient's life.However,the incidence of nausea and vomiting after TACE is very high,which is an important reason for the decline of patient treatment compliance,which seriously affects the quality of life and the effect of interventional therapy.This paper reviews the domestic and abroad literature concerning the nausea and vomiting in patients after TACE,focusing on the clinical features of nausea and vomiting,the risk factors and the assessment tools,so as to provide a scientific basis for clinical early identification and effective intervention of nausea and vomiting after TACE.(J Intervent Radiol,2024,33:565-570)